The Man Who Wrote the DSM Warned Us About Overdiagnosis — So Why Not Gender? - Allen Frances (#8)
10 April 2025
With Allen Frances
Global
Allen Frances chaired the DSM-IV Task Force and built his reputation on warnings against psychiatric overdiagnosis. Yet when the conversation turns to gender dysphoria, his trademark caution gives way to professed confusion. The episode illuminates a sharp paradox: the same diagnostic rigour Frances has applied to autism and depression is precisely what European systematic reviews have now applied to youth gender medicine — and found the evidence base critically wanting.
Allen Frances is one of the most credentialled critics of psychiatric overdiagnosis in the world. As chair of the DSM-IV Task Force, he watched the manual he helped shape become a vehicle for medicalising ordinary human variation, and he has spent the years since warning about the consequences: children labelled too early, medications prescribed too readily, and diagnoses that were meant to be time-limited hardening into permanent identities. His concerns about the autism diagnosis boom and the role of online communities in amplifying diagnostic self-identification have made him an unusual figure — a psychiatric insider who criticises the direction his own field has taken. Those warnings map with striking precision onto what independent systematic reviewers across Europe have concluded about the recent surge in gender dysphoria diagnoses among adolescents. Sweden's National Board of Health and Welfare, Finland's Council for Choices in Health Care, and the United Kingdom's Cass Review each applied the kind of evidence-based scrutiny Frances has long advocated — and each reached the same conclusion: the quality of evidence supporting hormonal and surgical interventions for gender-distressed young people is low, the risks are not adequately characterised, and diagnostic caution is warranted. The tension at the heart of this episode is therefore considerable. When the hosts press Frances on whether his philosophy of diagnostic restraint applies equally to gender dysphoria, the conversation becomes notably uncomfortable. Frances acknowledges confusion, concedes the field is genuinely difficult, and resists the inference that the same framework he invokes for autism or depression should govern gender medicine. For those tracking the evidence, that divergence is itself revealing: it suggests that ideological commitments can coexist with — and survive — even the most rigorous methodological instincts. Frances also discloses that he argued, during the DSM process, for removing gender identity as a formal diagnostic category. His reasoning centred on destigmatisation — classifying gender nonconformity as a disorder caused harm. The episode surfaces an irony in this position: the removal of a diagnostic gatekeeping requirement, intended to protect, may have contributed to clearing the path for a different kind of medicalisation, one driven by affirmative-care protocols that bypass the very clinical scrutiny Frances otherwise champions. The discussion also takes in detransition, the legal actions now being pursued by people who received irreversible interventions as minors, and the difficulty of establishing informed consent with adolescents facing permanent consequences. These are not peripheral questions. Courts in the United Kingdom and other European jurisdictions have begun examining consent standards in youth gender medicine with increasing seriousness, and the regulatory pullback in multiple countries reflects a growing recognition that clinical caution was set aside prematurely. What makes this conversation worth examining closely is the quality of the disagreement it produces. Frances is not a bad-faith participant; he shares many of the empirical instincts of the gender-critical position and applies them consistently elsewhere. The episode demonstrates that even a clinician who has dedicated a career to resisting diagnostic fashion can find reasons to exempt one area of medicine from that standard — and invites the question of what it would take to bring the evidence standard to bear consistently.
